1.
Immune checkpoint inhibitors have shown success in treating a subset of patients with certain late-stage cancers. However, these treatments fail in many other patients, d [...]
2024 | Abstract |
2.
Immune checkpoint inhibitors have shown success in treating a subset of patients with certain late-stage cancers. However, these treatments fail in many other patients, d [...]
2023-08-18 | Abstract |
3.
4.
Immune checkpoint blockade (ICB) has revolutionized the ways in which we treat some cancers, producing durable responses. However, many patients fail to respond to ICB. I [...]
2023-08-16 | Dissertation |
5.
T-cell large granular lymphocytic leukemia (T-LGLL) is a chronic lymphoproliferative disorder of mature cytotoxic T-cells. Accurate diagnosis is challenging, requiring in [...]
2022 | Scholarly project capstone (M.D.) |
6.
This novel computational framework for the analysis of single-cell gene expression data from human tumor samples enables the identification of molecular activity associat [...]
2024-09-18 | Dissertation |
7.
Mucosal-associated invariant T (MAIT) cells are an innate-like T cell subset important in the early response to bacterial and viral lung pathogens. Upon activation, MAIT [...]
2024-12-20 | Dissertation |
8.
9.
10.
Effective treatments for cancer have traditionally been divided into three separate arms: surgery, chemotherapy, and radiotherapy. Recently, however, a fourth arm, known [...]
2020 | Dissertation |